Gunilla Enblad – Tumörbiologi och kliniska studier av lymfom och prostatacancer

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma

Övergaard, Ninja; Lia, Kjersti; Collin, Jeremia; Asdahl, Peter H. et al.

Ingår i Blood Advances, s. 4889-4897, 2026

• DOI för AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma

Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Hesselager, Caroline; Hollander, Peter; Pettersson, Emma; Enblad, Gunilla et al.

Ingår i Blood Cancer Journal, 2026

• DOI för Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis
• Ladda ner fulltext (pdf) av Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Mattson Ulfstedt, Johan; Risebro, Ragnhild; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2026

• DOI för Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Exploratory study linking plasma proteomics to cardiotoxicity in Hodgkin lymphoma

Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients

Wenneras, Christine; Alsalihi, Rima; Karlsson, Veronica; Lewerin, Catharina et al.

Ingår i Leukemia and Lymphoma, s. 1327-1334, 2026

• DOI för Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
• Ladda ner fulltext (pdf) av Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients

Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Carlsten, Mattias; Lindfors Rossi, Elisa Linnea; Jaedersten, Martin; Tesi, Bianca et al.

Ingår i HemaSphere, 2025

• DOI för Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?
• Ladda ner fulltext (pdf) av Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Euler, Nora; Hellbacher, Erik; af Klint, Erik; Hansson, Monika et al.

Ingår i Clinical Immunology, 2025

• DOI för Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13
• Ladda ner fulltext (pdf) av Diffuse large B cell lymphoma in rheumatoid arthritis patients is associated with elevated B-cell driving factors including CXCL13

Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Jerkeman, Mats; Mellgren, Karin; Sonnevi, Kristina; Lisak, Mikael et al.

Ingår i Leukemia, s. 1256-1259, 2025

• DOI för Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden
• Ladda ner fulltext (pdf) av Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Ma, Jing; Sarén, Tina; Jin, Chuan; Kim, Hyeong Su et al.

Ingår i Cancer Immunology and Immunotherapy, 2025

• DOI för Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas
• Ladda ner fulltext (pdf) av Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; Larsson, Berit et al.

Ingår i European Urology Oncology, s. 1486-1495, 2025

• DOI för Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial
• Ladda ner fulltext (pdf) av Prognostic Value of the Circulating Tumor DNA Fraction in Metastatic Castration-resistant Prostate Cancer: Results from the ProBio Platform Trial

scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

Yadav, Ram Prakash; Xing, Pengwei; Zhao, Miao; Hollander, Peter et al.

Ingår i Nature Communications, 2025

• DOI för scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples
• Ladda ner fulltext (pdf) av scFFPE-ATAC enables high-throughput single cell chromatin accessibility profiling in formalin-fixed paraffin-embedded samples

Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

Harrysson, Sara; Eloranta, Sandra; Antonilli, Stefanie; Runason Simonsen, Mikkel et al.

Ingår i British Journal of Haematology, s. 1834-1839, 2025

• DOI för Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies
• Ladda ner fulltext (pdf) av Temporal trends in relative survival of diffuse large B-cell lymphoma in Sweden and Denmark in the era of targeted and cellular therapies

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Ingår i Nature Medicine, 2024

• DOI för Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Ladda ner fulltext (pdf) av Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Sköld, Camilla; Corvigno, Sara; Dahlstrand, Hanna; Enblad, Gunilla et al.

Ingår i Cancer Causes and Control, s. 1101-1109, 2024

• DOI för Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer
• Ladda ner fulltext (pdf) av Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer

Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Forsgren, Elin; Ekberg, Sara; Smedby, Karin E.; Nylund, Patrick et al.

Ingår i British Journal of Haematology, s. 1794-1803, 2024

• DOI för Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers
• Ladda ner fulltext (pdf) av Evaluation of coverage, generalisability and validity of the U-CAN lymphoma biobank in Sweden: A comparison with nationwide registers

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

Ren, Weicheng; Wan, Hui; Abd Own, Sulaf; Berglund, Mattias et al.

Ingår i Leukemia, s. 438-441, 2024

• DOI för Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
• Ladda ner fulltext (pdf) av Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis

Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Tarai, Sambit; Lundström, Elin; Sjöholm, Therese; Jönsson, Hanna et al.

Ingår i Heliyon, 2024

• DOI för Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors
• Ladda ner fulltext (pdf) av Improved automated tumor segmentation in whole-body 3D scans using multi-directional 2D projection-based priors

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Luminari, Stefano; Fossa, Alexander; Trotman, Judith; Molin, Daniel et al.

Ingår i Journal of Clinical Oncology, s. 13-18, 2024

• DOI för Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
• Ladda ner fulltext (pdf) av Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Ingår i Leukemia and Lymphoma, s. 534-537, 2024

• DOI för Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy

The National Swedish Lymphoma Register - a systematic validation of data quality

Smedby, Karin E.; Eloranta, Sandra; Wasterlid, Tove; Falini, Victor et al.

Ingår i Acta Oncologica, s. 563-572, 2024

• DOI för The National Swedish Lymphoma Register - a systematic validation of data quality
• Ladda ner fulltext (pdf) av The National Swedish Lymphoma Register - a systematic validation of data quality

Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study

Wästerlid, Tove; Dietrich, Caroline E.; Oksanen, Anna; Deleskog Spångberg, Linn et al.

Ingår i eJHaem, s. 516-526, 2024

• DOI för Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study
• Ladda ner fulltext (pdf) av Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study

A whole-body diffusion MRI normal atlas: development, evaluation and initial use

Sjöholm, Therese; Tarai, Sambit; Malmberg, Filip; Strand, Robin et al.

Ingår i Cancer Imaging, 2023

• DOI för A whole-body diffusion MRI normal atlas: development, evaluation and initial use
• Ladda ner fulltext (pdf) av A whole-body diffusion MRI normal atlas: development, evaluation and initial use

ADAR1-mediated RNA editing promotes B cell lymphomagenesis

Pecori, Riccardo; Ren, Weicheng; Pirmoradian, Mohammad; Binder, Marco et al.

Ingår i iScience, 2023

• DOI för ADAR1-mediated RNA editing promotes B cell lymphomagenesis
• Ladda ner fulltext (pdf) av ADAR1-mediated RNA editing promotes B cell lymphomagenesis

Next generation pan-cancer blood proteome profiling using proximity extension assay

Alvez, Maria Bueno; Edfors, Fredrik; von Feilitzen, Kalle; Zwahlen, Martin et al.

Ingår i Nature Communications, 2023

• DOI för Next generation pan-cancer blood proteome profiling using proximity extension assay
• Ladda ner fulltext (pdf) av Next generation pan-cancer blood proteome profiling using proximity extension assay

Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects

Huang, Dan; Berglund, Mattias; Damdimopoulos, Anastasios; Antonson, Per et al.

Ingår i Cancers, 2023

• DOI för Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects
• Ladda ner fulltext (pdf) av Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects

Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Sarén, Tina; Ramachandran, Mohanraj; Gammelgård, Gustav; Lövgren, Tanja et al.

Ingår i Clinical Cancer Research, s. 4139-4152, 2023

• DOI för Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
• Ladda ner fulltext (pdf) av Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats et al.

Ingår i Blood Advances, s. 5304-5313, 2023

• DOI för Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Ginman, Beatrice; Pahnke, Simon; Freyhult, Eva; Hoffman, Tove et al.

Ingår i Acta Oncologica, s. 1707-1715, 2023

• DOI för Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2
• Ladda ner fulltext (pdf) av Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Weibull, Caroline E.; Wasterlid, Tove; Wahlin, Bjorn Engelbrekt; Andersson, Per-Ola et al.

Ingår i HemaSphere, 2023

• DOI för Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden
• Ladda ner fulltext (pdf) av Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Apollonio, Benedetta; Spada, Filomena; Petrov, Nedyalko; Cozzetto, Domenico et al.

Ingår i Journal of Clinical Investigation, 2023

• DOI för Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma
• Ladda ner fulltext (pdf) av Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma

Advances in immune therapies in hematological malignancies

Mazzarella, Luca; Enblad, Gunilla; Olweus, Johanna; Malmberg, Karl-Johan et al.

Ingår i Journal of Internal Medicine, s. 205-220, 2022

• DOI för Advances in immune therapies in hematological malignancies
• Ladda ner fulltext (pdf) av Advances in immune therapies in hematological malignancies

Checkpoint CD47 expression in classical Hodgkin lymphoma

Gholiha, Alex Reza; Hollander, Peter; Löf, Liza; Glimelius, Ingrid et al.

Ingår i British Journal of Haematology, s. 580-589, 2022

• DOI för Checkpoint CD47 expression in classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Checkpoint CD47 expression in classical Hodgkin lymphoma

COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients

Sundberg, Emil; Hoffman, Tove; Nilsson, Anna; Pahnke, Simon et al.

Ingår i Pediatric Blood & Cancer, 2022

• DOI för COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients
• Ladda ner fulltext (pdf) av COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

Hellström, Vivan; Tufveson, Gunnar; Loskog, Angelica; Bengtsson, Mats et al.

Ingår i PLOS ONE, 2022

• DOI för Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis
• Ladda ner fulltext (pdf) av Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Gholiha, Alex R.; Hollander, Peter; Löf, Liza; Larsson, Anders et al.

Ingår i Cancers, 2022

• DOI för Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue
• Ladda ner fulltext (pdf) av Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Ingår i Journal of Clinical Oncology, s. 1487-1496, 2022

• DOI för Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
• Ladda ner fulltext (pdf) av Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Bratulic, Sinisa; Limeta, Angelo; Dabestani, Saeed; Birgisson, Helgi et al.

Ingår i Proceedings of the National Academy of Sciences of the United States of America, 2022

• DOI för Noninvasive detection of any-stage cancer using free glycosaminoglycans
• Ladda ner fulltext (pdf) av Noninvasive detection of any-stage cancer using free glycosaminoglycans

Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Abdulla, Maysaa; Hollander, Peter; Lindskog, Cecilia; Sundström, Christer et al.

Ingår i Acta Oncologica, s. 824-829, 2022

• DOI för Outcome in PCNSL patients and its association with PD-L1+leukocytes in the tumor microenvironment

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Ingår i British Journal of Haematology, s. 267-277, 2022

• DOI för Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients
• Ladda ner fulltext (pdf) av Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients

Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Sköld, Camilla; Koliadi, Anthoula; Enblad, Gunilla; Stålberg, Karin et al.

Ingår i International Journal of Cancer, s. 773-781, 2022

• DOI för Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes
• Ladda ner fulltext (pdf) av Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Elsawy, Mahmoud; Chavez, Julio C.; Avivi, Irit; Larouche, Jean-Francois et al.

Ingår i Blood, s. 2248-2260, 2022

• DOI för Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

Sabaa, Amal Abu; Shen, Qiujin; Lennmyr, Emma; Enblad, Anna Pia et al.

Ingår i New Biotechnology, s. 21-29, 2022

• DOI för Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls
• Ladda ner fulltext (pdf) av Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls

The dual role of CD70 in B‐cell lymphomagenesis

Nie, Man; Ren, Weicheng; Ye, Xiaofei; Berglund, Mattias et al.

Ingår i Clinical and Translational Medicine, 2022

• DOI för The dual role of CD70 in B‐cell lymphomagenesis
• Ladda ner fulltext (pdf) av The dual role of CD70 in B‐cell lymphomagenesis

Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Skaftason, Aron; Qu, Ying; Abdulla, Maysaa; Nordlund, Jessica et al.

Ingår i Genes, Chromosomes and Cancer, s. 27-36, 2022

• DOI för Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
• Ladda ner fulltext (pdf) av Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Sjöholm, Therese; Korenyushkin, Alexander; Gammelgård, Gustav; Sarén, Tina et al.

Ingår i Cancer Imaging, 2022

• DOI för Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
• Ladda ner fulltext (pdf) av Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study

Sabaa, Amal Abu; Mörth, Charlott; Hasselblom, Sverker; Hedström, Gustaf et al.

Ingår i British Journal of Haematology, s. 906-914, 2021

• DOI för Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
• Ladda ner fulltext (pdf) av Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Wenthe, Jessica; Naseri, Sedigheh; Labani-Motlagh, Alireza; Enblad, Gunilla et al.

Ingår i Cancer Immunology and Immunotherapy, s. 2851-2865, 2021

• DOI för Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
• Ladda ner fulltext (pdf) av Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

Ullgren, Helena; Camuto, Angela; Rosas, Sumy; Pahnke, Simon et al.

Ingår i Acta Oncologica, s. 1459-1465, 2021

• DOI för Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
• Ladda ner fulltext (pdf) av Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study

High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Andersson, Anne; Enblad, Gunilla; Erlanson, Martin; Johansson, Ann-Sofie et al.

Ingår i Upsala Journal of Medical Sciences, 2021

• DOI för High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
• Ladda ner fulltext (pdf) av High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Ingår i Blood Cancer Journal, 2021

• DOI för Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
• Ladda ner fulltext (pdf) av Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Abdulla, Maysaa; Alexsson, Andrei; Sundström, Christer; Ladenvall, Claes et al.

Ingår i Acta Oncologica, s. 531-538, 2021

• DOI för PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
• Ladda ner fulltext (pdf) av PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS

Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Mörth, Charlott; Sabaa, Amal Abu; Freyhult, Eva; Christersson, Christina et al.

Ingår i Cardio-Oncology, 2021

• DOI för Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Plasma proteome profiling of cardiotoxicity in patients with diffuse large B-cell lymphoma

Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Kinch, Amelie; Baecklund, Eva; Molin, Daniel; Pauksen, Karlis et al.

Ingår i Acta Oncologica, s. 771-778, 2021

• DOI för Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Vajavaara, Heli; Ekeblad, Frida; Holte, Harald; Jorgensen, Judit et al.

Ingår i Haematologica, s. 2502-2506, 2021

• DOI för Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Gholiha, Alex R.; Hollander, Peter; Glimelius, Ingrid; Hedström, Gustaf et al.

Ingår i Blood Advances, s. 1671-1681, 2021

• DOI för Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Mattsson Ulfstedt, Johan; Venge, Per; Holmgren, Sofia; Enblad, Gunilla et al.

Ingår i Upsala Journal of Medical Sciences, 2021

• DOI för Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
• Ladda ner fulltext (pdf) av Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

Sima, Andreea; Hollander, Peter; Baecklund, Eva; Smedby, Karin E. et al.

Ingår i British Journal of Haematology, s. 568-579, 2021

• DOI för Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden
• Ladda ner fulltext (pdf) av Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden

CD30 expression and survival in posttransplant lymphoproliferative disorders

Kinch, Amelie; Amini, Rose-Marie; Hollander, Peter; Molin, Daniel et al.

Ingår i Acta Oncologica, s. 673-680, 2020

• DOI för CD30 expression and survival in posttransplant lymphoproliferative disorders
• Ladda ner fulltext (pdf) av CD30 expression and survival in posttransplant lymphoproliferative disorders

Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Amini, Rose-Marie; Ljungström, Viktor; Abdulla, Maysaa; Cavelier, Lucia et al.

Ingår i American Journal of Hematology, 2020

• DOI för Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome

Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival

Persson Skare, Tor; Sjöberg, Elin; Berglund, Mattias; Smith, Ross O. et al.

Ingår i eJHaem, s. 199-207, 2020

• DOI för Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
• Ladda ner fulltext (pdf) av Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus et al.

Ingår i British Journal of Haematology, s. 685-691, 2020

• DOI för No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Wästerlid, Tove; Harrysson, Sara; Andersson, Therese M-L; Ekberg, Sara et al.

Ingår i American Journal of Hematology, s. 740-748, 2020

• DOI för Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma

Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Hollander, Peter; Ginman, Beatrice; Molin, Daniel; Enblad, Gunilla et al.

Ingår i Immunobiology, 2020

• DOI för Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma

Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Abdulla, Maysaa; Guglielmo, Priscilla; Hollander, Peter; Åström, Gunnar et al.

Ingår i European Journal of Haematology, s. 207-213, 2020

• DOI för Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma
• Ladda ner fulltext (pdf) av Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma

Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study

Benoni, Henrik; Eloranta, Sandra; Dahle, Dag O.; Svensson, My H. S. et al.

Ingår i Transplant International, s. 1700-1710, 2020

• DOI för Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study
• Ladda ner fulltext (pdf) av Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study

The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Crippa, Alessio; De Laere, Bram; Discacciati, Andrea; Larsson, Berit et al.

Ingår i Trials, 2020

• DOI för The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer
• Ladda ner fulltext (pdf) av The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Niinivirta, Marjut; Georganaki, Maria; Enblad, Gunilla; Lindskog, Cecilia et al.

Ingår i BMC Cancer, 2020

• DOI för Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib
• Ladda ner fulltext (pdf) av Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Amini, Rose-Marie; Enblad, Gunilla; Hollander, Peter; Laszlo, S. et al.

Ingår i BMC Cancer, 2019

• DOI för Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients
• Ladda ner fulltext (pdf) av Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients

Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Mörth, Charlott; Valachis, Antonios; Sabaa, Amal Abu; Marshall, Katharina et al.

Ingår i Acta Oncologica, s. 1170-1177, 2019

• DOI för Autoimmune disease in patients with diffuse large B-cell lymphoma: occurrence and impact on outcome

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Kinch, Amelie; Sundström, Christer; Baecklund, Eva; Backlin, Carin et al.

Ingår i Leukemia and Lymphoma, s. 376-384, 2019

• DOI för Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
• Ladda ner fulltext (pdf) av Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

Pedersen, Mette A.; Gormsen, Lars C.; Kamper, Peter; Wassberg, Cecilia et al.

Ingår i British Journal of Haematology, s. 431-439, 2019

• DOI för Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Gholiha, Alex R.; Hollander, Peter; Hedström, Gustaf; Sundström, Christer et al.

Ingår i British Journal of Haematology, s. 192-201, 2019

• DOI för High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Ingår i Acta Oncologica, s. 1655-1659, 2019

• DOI för Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

Niinivirta, Marjut; Enblad, Gunilla; Lindskog, Cecilia; Pontén, Fredrik et al.

Ingår i Journal of Cancer, s. 3224-3231, 2019

• DOI för Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib
• Ladda ner fulltext (pdf) av Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Gammelgård, Gustav; Wenthe, Jessica et al.

Ingår i Clinical Cancer Research, s. 6185-6194, 2018

• DOI för A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Hollander, Peter; Rostgaard, Klaus; Ekström-Smedby, Karin; Molin, Daniel et al.

Ingår i European Journal of Haematology, s. 88-97, 2018

• DOI för An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome
• Ladda ner fulltext (pdf) av An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Mörth, Charlott; Valachis, Antonis; Sabaa, Amal Abu; Molin, Daniel et al.

Ingår i Annals of Hematology, s. 2129-2135, 2018

• DOI för Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?
• Ladda ner fulltext (pdf) av Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Hollander, Peter; Amini, Rose-Marie; Ginman, Beatrice; Molin, Daniel et al.

Ingår i PLOS ONE, 2018

• DOI för Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma

Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients

Ednersson, Susanne Bram; Stenson, Martin; Stern, Mimmie; Enblad, Gunilla et al.

Ingår i British Journal of Haematology, s. 770-781, 2018

• DOI för Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients

Imiomics Using Whole-body FDG PET/MR in Staging and Treatment Response Evaluation of Non-Hodgkin Lymphoma Patients Treated With CAR-T Cells

Guglielmo, P.; Sjöholm, Therese; Enblad, Gunilla; Strand, Robin et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Harrysson, Sara; Eloranta, Sandra; Ekberg, Sara; Enblad, Gunilla et al.

Ingår i Blood, 2018

• DOI för Incidence and Outcome of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in a Population-Based Cohort of 3165 Patients in Sweden

Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013

Eloranta, Sandra; Brånvall, Elsa; Celsing, Fredrik; Papworth, Karin et al.

Ingår i European Journal of Haematology, s. 61-68, 2018

• DOI för Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Ekberg, Sara; Jerkeman, Mats; Andersson, Per-Ola; Enblad, Gunilla et al.

Ingår i American Journal of Hematology, s. 1020-1028, 2018

• DOI för Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Smedby, Karin Ekstrom; Harrysson, Sara; Andersson, Per-Ola; Enblad, Gunilla et al.

Ingår i Blood, 2018

• DOI för Outcome and Determinants of Failure to Complete 6-8 Cycles of Primary R-CHOP Treatment for Reasons Unrelated to Progression Among Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

Wasterlid, T.; Biccler, J. L.; Brown, P. N.; Bogsted, M. et al.

Ingår i Annals of Oncology, s. 1882-1883, 2018

• DOI för Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Ingår i Acta Oncologica, s. 187-194, 2018

• DOI för U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Ladda ner fulltext (pdf) av U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Ingår i Acta Oncologica, s. 106-109, 2017

• DOI för Core needle biopsies for the diagnosis of diffuse large B-cell lymphoma - a great concern for research

Does the omission of vincristine affect outcome and survival in patients with diffuse large B-cell lymphoma?

Mörth, Charlott; Valachis, Antonis; Abu Sabaa, Amal; Hedström, Gustaf et al.

Ingår i Annals of Oncology, 2017

Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Hellström, Vivan; Tufveson, Gunnar; Wallgren, AnnaCarin; Loskog, Angelica et al.

Ingår i American Journal of Transplantation, s. 472-472, 2017

• DOI för Donor Derived and BK Virus Positive Urologic Cancers After Renal Transplantation

Estrogen receptor beta 1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

Hasni, Muhammad Sharif; Berglund, Mattias; Yakimchuk, Konstantin; Guan, Jiyu et al.

Ingår i Leukemia and Lymphoma, s. 418-427, 2017

• DOI för Estrogen receptor beta 1 in diffuse large B-cell lymphoma growth and as a prognostic biomarker

Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

Delforoush, Maryam; Berglund, Mattias; Edqvist, Per-Henrik; Sundström, Christer et al.

Ingår i European Journal of Haematology, s. 52-56, 2017

• DOI för Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma

High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer

Hellström, Vivan; Lorant, Tomas; Döhler, Bernd; Tufveson, Gunnar et al.

Ingår i Transplantation, s. 1295-1302, 2017

• DOI för High posttransplant cancer incidence in renal transplanted patients with pretransplant cancer

High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Hollander, Peter; Kamper, Peter; Smedby, Karin Ekstrom; Enblad, Gunilla et al.

Ingår i Blood Advances, s. 1427-1439, 2017

• DOI för High proportions of PD-1⁺ and PD-L1⁺ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Immunological biomarkers correlate to survival in CAR19-treated patients

Lövgren, Tanja; Wenthe, Jessica; Karlsson, S. C. Hannah; Gammelgård, Gustav et al.

Ingår i Scandinavian Journal of Immunology, s. 337-337, 2017

Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Enblad, Gunilla; Martinsson, Gustaf; Baecklund, Eva; Hesselager, Göran et al.

Ingår i Acta Oncologica, s. 599-607, 2017

• DOI för Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing

Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.

Hellström, Vivan; Enström, Ylva; Enblad, Gunilla; Tufveson, Gunnar et al.

Ingår i Acta Dermato-Venereologica, s. 751-753, 2017

• DOI för Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma.

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Niinivirta, Marjut; Enblad, Gunilla; Edqvist, Per-Henrik D; Pontén, Fredrik et al.

Ingår i Journal of Cancer, s. 3975-3983, 2017

• DOI för Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients
• Ladda ner fulltext (pdf) av Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

Niinivirta, Marjut; Enblad, Gunilla; Edqvist, Per-Henrik; Pontén, Fredrik et al.

Ingår i Journal of Cancer Research and Clinical Oncology, s. 961-970, 2017

• DOI för Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
• Ladda ner fulltext (pdf) av Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib

A Clinical Trial Using Third Generation CD19 Targeting CAR T Cells for Relapsed Lymphoma and Leukemia

Enblad, Gunilla; Karlsson, Hannah; Wenthe, Jessica; Wikström, Kristina I. et al.

Ingår i Molecular Therapy, 2016

A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Abdulla, Maysaa; Laszlo, Sofia; Triumf, Johanna; Hedström, Gustaf et al.

Ingår i Acta Oncologica, s. 1126-1131, 2016

• DOI för A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma

Johnson, Peter; Federico, Massimo; Kirkwood, Amy; Fossa, Alexander et al.

Ingår i New England Journal of Medicine, s. 2419-2429, 2016

• DOI för Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma